Alkyl Amines Chemicals has received a credit rating reaffirmation from CRISIL Ratings Limited, maintaining its strong position in the chemicals sector. The rating agency has reviewed and reaffirmed the company's existing ratings on its bank facilities, demonstrating confidence in the company's financial stability and creditworthiness.

Rating Details and Facility Coverage

CRISIL has reaffirmed comprehensive ratings covering Alkyl Amines Chemicals' total bank loan facilities worth ₹189.38 crores. The rating review encompasses both long-term and short-term credit facilities, providing a complete assessment of the company's debt profile.

Regulatory Compliance and Disclosure

The company announced this rating reaffirmation through official communications to both BSE Limited and The National Stock Exchange of India Limited. This disclosure was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency for investors and stakeholders.

Credit Rating Significance

The AA-/Stable long-term rating indicates a high degree of safety regarding timely servicing of financial obligations, with very low credit risk. The A1+ short-term rating represents the highest category for short-term instruments, indicating a very strong degree of safety regarding timely payment of financial obligations. The stable outlook suggests that the rating is unlikely to change in the near term.

Corporate Communication

The rating information has been made available on the company's official website at www.alkylamines.com , ensuring accessibility for all stakeholders. The disclosure was signed by Chintamani D. Thatte, General Manager (Legal) & Company Secretary & Compliance Officer, maintaining proper corporate governance standards in the communication process.

Alkyl amines chemicals Limited has completed the allotment of 75 equity shares to eligible employees under its Employee Stock Option Plan 2018 (ESOP-2018) on December 19, 2025. The allotment was approved through a circular resolution passed by the Nomination and Remuneration Committee of the Board of Directors on the same date.

Share Allotment Details

The company allotted 75 equity shares with a face value of ₹2.00 each to eligible employees upon exercise of stock options granted under the AACL-ESOP 2018 scheme. This allotment represents the execution of previously granted employee stock options under the company's established employee benefit program.

Impact on Share Capital

The allotment has resulted in a marginal increase in the company's paid-up equity share capital. The capital structure has been updated to reflect the new share issuance under the employee stock option plan.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification has been filed with both BSE (scrip code: 506767) and NSE (symbol: ALKYLAMINE) as required under SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The original ESOP-2018 scheme filing dates were February 2, 2019 for BSE and February 4, 2019 for NSE. No lock-in period applies to these allotted shares, and they will rank pari passu with existing equity shares of the company.

Listing and Fee Structure

Since the company's paid-up capital remains within the ₹100 crores slab, no additional listing fees are payable for the newly issued equity shares. The company has already paid the requisite listing fees for this capital range, covering the current allotment under the existing fee structure.

The allotment demonstrates the company's commitment to its employee incentive programs while maintaining compliance with all regulatory requirements for listed entities.